Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The analysis of circulating tumour DNA will be postponed due to COVID-19, as the clinics in Spain have had limited opportunities to carry out the planned blood sampling

Since the NeoFox study was put on hold in March 2020, the clinics have had limited possibilites to carry out follow-up blood sampling of patients included in the study. As a result, a number of blood samples which are critical for the planned analysis of circulating tumour DNA could not be collected. WntResearch has now restarted the NeoFox study in Spain, but the COVID-19 situation is still posing problems in both Hungary and Spain, and the inclusion of new patients thus remains slow.The Spanish authorities have recently changed their recommendations, and decisions regarding clinical trial

Integrum granted US patent for attachment device allowing natural wrist rotation for bone-anchored prostheses

Integrum, a recognized global leader in bone-anchored prostheses, has been granted a patent by the US Patent and Trademark Office for an attachment device that allows natural wrist rotation for bone-anchored prostheses. Integrum has been granted a patent by the US Patent and Trademark Office for an attachment device that allows natural wrist rotation for bone-anchored prostheses. Upper extremity amputees with an amputation below the elbow (also known as trans-radial amputation patients) who opt for bone-anchored prostheses solutions, have two implants placed in the residual

Invitation to SCA’s Q3 2020 press conference October 30, 10.00 CET

The press conference, held in connection with the publication of SCA’s interim report for the third quarter of 2020, will also be available via webcast or by phone.The interim report will be published on October 30, 2020, at approximately 08:00 CET. The subsequent press conference will be held at 10:00 CET at Kreugersalen, Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm. At the press conference, President and CEO Ulf Larsson and CFO Toby Lawton will present and answer questions regarding the report. Press conference:Date and time: Friday October 30, 2020, 10.00 CET.Venue:

Sandvik AB – Nomination Committee for the 2021 Annual General Meeting

In 2020 Sandvik AB’s Annual General Meeting adopted an instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise. Pursuant to this instruction the company shall have a Nomination Committee comprised of members appointed by each of the four principal shareholders in terms of votes on the last banking day of August, as well as the Chairman of the Board (convenor). The Nomination Committee has now been appointed and consists of the following members: · Fredrik Lundberg, AB Industrivärden, Chairman of the Nomination

Eco Wave Power Announces Performance Improvements and Significant Cost Reductions from Gibraltar Wave Energy Project

Stockholm, Sweden, September 24, 2020 --- Onshore wave energy developer Eco Wave Power (Stock Symbol: ECOWVE) today announces improvements in power output and significant cost reductions for the company’s grid-connected wave energy power plant in Gibraltar. Dr. Guang Li and Dr. Kamyar Mehran from the Queen Mary University of London   As a result of an upgrade of the automation and control system, as well as experience gained in operations and maintenance, Eco Wave Power has managed to significantly increase uptime for the Gibraltar power plant. In 2018–2019, power

KONE to equip B4 Grande luxury residential tower in Dubai

KONE Corporation, press release, September 24, 2020KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply 17 elevators to B4 Grande, a new high-end residential tower located in the Opera Downtown District in Dubai, United Arab Emirates. The 287-meter and 72-storey high skyscraper will accommodate 882 luxury apartments as well as amenities and retails outlets on the promenade level. The apartment types include one to four bedroom units and large penthouses that will be located on the highest floors. The residents of B4 Grande will have

Biotage appoints Nomination Committee

A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 4 June 2020. The Nomination Committee shall, before the Annual General Meeting 2021, prepare proposal for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, election of Auditors, the determination of fees and matters pertaining thereto. The members of

Vattenfall and Glennmont sign wind power balancing services deal

Vattenfall and the European clean energy investor Glennmont Partners have signed a long-term agreement to provide balancing services for Piiparinmäki, a new 211 MW onshore wind farm that will become the largest in Finland.The onshore wind farm Piiparinmäki, acquired by Glennmont Partners in September last year, is located in central Finland near Kajaani and will have 41 turbines. Once operational, Piiparinmäki, will be the largest wind farm in Finland with an estimated yearly production of approximately 700 GWh. Thereby, it will become a significant wind power asset in the Nordic Nord Pool

Notice to attend the Extraordinary General Meeting of Skanska AB (publ)

Shareholders in Skanska AB (publ), Reg. No 556000-4615 (the “Company”), are hereby invited to participate in the Extraordinary General Meeting (the “Meeting”) on Thursday October 22, 2020 for decision on dividend. At the Annual General Meeting on March 26, 2020 it was decided in accordance with the motion by the Board of Directors (the “Board”) that no dividend would be distributed to the shareholders due to the prevailing uncertainty caused by COVID-19. During the recent months, uncertainty has decreased, but there is still reason to be prudent. The Board has decided, after an overall

New PEMA Skymaster PRO series: programmable, digital, visual

  Pemamek Ltd. unveils the new welding positioner series, PEMA Skymaster PRO. The newly released welding positioner represents a fusion of modern digitality and Pemamek’s signature positioning technology. The PEMA Skymaster PRO series expands the handling capabilities of previous Skymaster positioners with new intelligent PRO- software that enables pre-programming of work cycles and handling positions. Thanks to the visual software tool, the operator gets a better understanding of the overall production, improves manufacturing capacity, and saves time especially in serial

Swedbank Robur presents its first ‘Paris Aligned’ funds

Swedbank Robur has now classified its first ‘Paris Aligned’ funds, the Robur Access Edge funds. The classification and method are based on the EU Sustainable Finance climate benchmark guidelines, aligning fund investments with the climate targets in the Paris agreement.Swedbank Robur’s Paris Aligned funds create transparency for customers who want to save with sustainability and the climate in focus. The method is based on the EU Sustainable Finance climate benchmark guidelines, which put the portfolio companies’ emission targets in focus. For example, the funds’ carbon emission footprint

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 54 - 24 SEPTEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Port of Trelleborg offers their shipping customers reliable and fast internet with Nowhere Networks

Port of Trelleborg, the largest RoRo port in Scandinavia, has chosen Nowhere Networks as its strategic supplier for radio based fast internet to their shipping customers. Implementation will start shortly and before the end of this year all ferries of the Port of Trelleborg will have the opportunity to connect via radio link and receive up to 300 Mbit/s internet. Starting at the beginning of 2021, TT-Line will be the first shipping company to use high-speed internet via the joint collaboration between Nowhere Networks and the Port of Trelleborg.For some time now, the Port of Trelleborg has

BRAbank ASA: BRA-ME - CEO resigns October 1[st]

(Bergen, 24 September 2020): Reference is made to stock exchange release 12 June 2020, announcing that BRAbank ASA (BRAbank) and Easybank ASA (Easybank) will merge with the intent to create a leading consumer and SME digital niche bank with a Nordic footprint. As a part of the ongoing merger, BRAbank’s current CEO Hans Kristian Ljøen, will step down and take on the role as a strategic adviser until the end of November 2020. “Hans has played an instrumental role in the Bank’s turnaround and in restoring profitability. The board would like to thank Hans for his strong commitment and

Metsä Fibre and ANDRITZ sign preliminary agreement on advanced wood raw material processing equipment for the Kemi bioproduct mill

Metsä Fibre press release 24.9.2020Metsä Fibre, part of Metsä Group, and ANDRITZ signed a preliminary agreement on wood raw material reception and feed equipment for the Kemi bioproduct mill. The delivery includes two automated overhead cranes, as well as their installation and commissioning. This type of fully autonomous, AI-based equipment is a new solution for the reception, storage and process feeding of wood raw material, even on a global scale. It also enables the minimisation of the area needed at the mill for storing wood raw material. The domestic rate of the delivery is 45% and

Attana and ExpreS[2]ion Biotech have signed a Development & Supply Agreement

Attana AB (“Attana”) hereby announces that it has signed a heads of terms agreement regarding the development and supply of novel proteins from ExpreS[2]ion Biotechnologies ApS (“ExpreS[2]ion"). The first target protein will be the ExpreS[2]ion-produced SARS-CoV-2 spike and receptor-binding-domain (RBD) antigen used in ExpreS[2]ion’s COVID-19 vaccine program. Attana will now be able to offer customers utilising its AVA diagnostic platform, this and other novel ExpreS[2]ion proteins. The parties are not disclosing the commercial terms of the agreement.In early June, ExpreS[2]ion announced (

Heimstaden Bostad AB forms new joint ventures with Magnolia Bostad and Derome

Heimstaden Bostad AB has signed an agreement with Magnolia Bostad AB to jointly acquire land from Derome AB in Kungsbacka, Sweden. Together, the two companies will develop and construct approximately 1,600 apartments with a total area of 100,000 sq.m., subject to regulatory approval. The project value upon completion is estimated to SEK 3.0 billion. With this project, Heimstaden Bostad AB will significantly strengthen its presence in the Gothenburg region. In conjunction with the aforementioned transaction, Heimstaden Bostad AB, Magnolia Bostad AB and Derome AB have entered into a joint

Magnolia Bostad forms new joint ventures with Heimstaden Bostad and Derome

Magnolia Bostad has signed agreements with Heimstaden Bostad regarding the joint development of land for the construction of apartment blocks next to Hede station in Kungsbacka. The project consists of around 1,600 apartments with a total area of about 100,000 m[2] GFA. The seller is Derome, which will continue to have a large share of land in the total development area after the transaction. In connection with Derome selling the land next to Hede station in Kungsbacka, Heimstaden Bostad, Magnolia Bostad  and Derome have signed a agreement regarding a jointly-owned company where the

Heimstaden Bostad AB forms new joint ventures with Magnolia Bostad and Derome

Heimstaden AB's subsidiary, Heimstaden Bostad AB has signed an agreement with Magnolia Bostad AB to jointly acquire land from Derome AB in Kungsbacka, Sweden. Together, the two companies will develop and construct approximately 1,600 apartments with a total area of 100,000 sq.m., subject to regulatory approval. The project value upon completion is estimated to SEK 3.0 billion. With this project, Heimstaden Bostad AB will significantly strengthen its presence in the Gothenburg region. In conjunction with the aforementioned transaction, Heimstaden Bostad AB, Magnolia Bostad AB and Derome

FREYR adds VP of Operations and product engineer to advance Norway’s first LiB battery production facility

FREYR has appointed Kenneth Yan as VP of Operations and Eirik Børsheim as Product Manager to advance Norway’s first LiB battery production facility. Both will join the company later this year to accelerate FREYRs development of the fast-track and giga-scale facilities in Mo i Rana, Norway.“Our business model and strategy combined with our expanding team of industry professionals and the comparative benefits of Norway, attract some of the best talents in the battery industry”, says CEO Tom Einar Jensen The new VP of Operations, Kenneth Yan, has for the past two years been CEO of Cham

BioStock: Ultimovacs on track to develop universal cancer vaccine

Cancer’s heavy burden on society has created a strong demand for new innovative therapeutic solutions. Over the last decade, immunotherapy has emerged as one of the most promising fields within oncology, and several biotech and pharma companies are exploiting this promise by developing immunotherapy-based drugs. Norwegian Ultimovacs is one of them. Their immunotherapy technology may work as a vaccine for treating all forms of cancer. BioStock takes an in-depth look at the company.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-on-track-to-develop-universal-

Exercise of options

Issue of equityCompany announcement, 24 September 2020 at 9.15 (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received notifications from option holders to exercise D options over 15,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 1.00) per share under the Company’s 2015 Option Plan (“New Ordinary Shares”). The terms and conditions of the 2015 Option Plan are available on the Company’s website at https://www.faron.com/sites/default/files/Option%20Plan%

Half-year report

· Development of novel cancer immunotherapy Clevegen[®] (bexmarilimab) continues in Phase I/II MATINS trial across 10 tumour types · IV interferon beta-1a, Traumakine[®], being investigated as potential COVID-19 treatment in two ongoing global trials with preparations for US trial underway · Successful €14 million placing in April strengthens Company’s balance sheet · Additional grants of €3.3 million and €4.6 million loans awarded to drive R&D and CMC programmesHalf-year report, 24 September 2020 at 9.00 AM (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First

There are no items matching the current filter
There are no more items matching the current filter
Back to top